Skip to main content
. 2020 Aug 19;12(9):2339. doi: 10.3390/cancers12092339

Figure 1.

Figure 1

Post-transplant outcomes for 743 adults with AML undergoing allogeneic HCT while in first or second morphologic remission, stratified by conditioning intensity. (A) Cumulative risk of relapse. (B) Relapse-free survival. (C) Overall survival. (D) Cumulative risk of non-relapse mortality. Outcome estimates are shown separately for MAC patients (n = 441), RIC patients (n = 130), and NMA HCT patients (n = 172), respectively.